No Prescription |
 |
 | ||
|
DUPHASTON Generic Dydrogesterone |
|
| ||
No Prescription » Prescription Drugs 6 » DUPHASTON Generic Dydrogesterone It is Progestogen.Used in the treatment of menstrual disorders and in the management of recurrent miscarriage/threatened miscarriage. Buy DUPHASTON Generic Dydrogesterone and other Prescription Drugs 6 products online at Medstore. 487
About DUPHASTON Generic Dydrogesterone: Product Type: Prescription Drugs 6 DUPHASTON ( Generic Dydrogesterone ) DUPHASTON (Generic Dydrogesterone) Generic Dydrogesterone 10mg Tabs 10 Generic Dydrogesterone DUPHASTON
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
